(Q54257982)
Statements
A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma. A Southwest Oncology Group study. (English)
1 reference
Zidar BL
1 reference
Metch B
1 reference
Balcerzak SP
1 reference
Pierce HI
1 reference
Militello L
1 reference
Keppen MD
1 reference
Berenberg JL
1 reference
1 November 1992
1 reference
1 reference
70
1 reference
10
1 reference
2547-2551
1 reference
Identifiers
1 reference